17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion

Molecular Cancer Research

Volumn 6, Issue 11, 2008, Pages 1657-1665

  Kim, Mi Suk ^a,c   Kwak, Hee Jin ^a   Lee, Ji Woo ^a   Kim, Hea Jin ^a   Park, Myung Jin ^b   Park, Jong Bae ^a   Choi, Kyung Ho ^a   Yoo, Heon ^a   Shin, Sang Hoon ^a   Shin, Woon Seob ^d   Song, Eun Sook ^c   Lee, Seung Hoon ^a  

^a National Cancer Center   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE B; HEAT SHOCK PROTEIN 90 INHIBITOR; HYALURONIC ACID; I KAPPA B; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TANESPIMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

BENZOQUINONES; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GLIOMA; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYALURONIC ACID; I-KAPPA B KINASE; I-KAPPA B PROTEINS; LACTAMS, MACROCYCLIC; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 56449114760     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0034     Document Type: Article

References (35)

1. Von Deimling A, Louis DN, Weiestler OD. Molecular pathways in the formation of gliomas. Glia 1995;15:328-38.
2. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawava R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 1993;53:2208-11.
3. Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 1997;57:773-7.
4. Nakagawa T, Kubota T, Kabuto M, Kodera T. Hyaluronic aid facilitates glioma cell invasion in vitro. Anticancer Res 1996;16:2917-22.
5. Merzak A, Koocheckpour S, Pilkington, GJ. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994;54:3988-92.
6. Park MJ, Kim MS, Park IC, et al. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioma cells through focal adhesion kinase dephosphorylation. Cancer Res 2002;21:6318-22.
7. Alaniz L, Garcia M, Cabrera P, et al. Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-κB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun 2004;324:736-43.
8. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 2001;107:241-6.
9. Karin M, Cao Y, Greten FR. Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-10.
10. Neckers L, Neckers K. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics-an update. Expert Opin Emerg Drugs 2005;10:137-49.
11. Lewis J, Devin A, Miller A, et al. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-nB activation. J Biol Chem 2000;271:10519-26.
12. Broemer M, Krappmann D, Scheidereit C. Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 2004;23:5378-86.
13. Zagzag D, Nomura M, Friedlander DR, et al. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1α) in glioma cell invasion. J Cell Physiol 2003;196:394-402.
14. Pittet JF, Lee H, Pespeni M, O'Mahony A, Roux J, WelchWJ. Stress-induced inhibition of the NF-κB signaling pathway results from the insolubilization of the IκB kinase complex following its dissociation from heat shock protein 90. J Immunol 2005;174:384-94.
15. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y. 17-Allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-κB pathway. Cancer Res 2006; 66:1089-95.
16. Yaron A, Gonen H, Alkalay I, et al. Inhibition of NF-κ-B cellular function via specific targeting of the I-κ-B-ubiquitin ligase. EMBO J 1997;16:6486-94.
17. Chen Z, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-97.
18. Kim MS, Park MJ, Kim SJ, et al. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of gliomas cells. Int J Oncol 2005;27:839-46.
19. Bohle AS, Kalthoff H. Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 1999;384:133-40.
20. Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
21. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
22. Baichwal VR, Baeuerle PA. Activate NF-κB or die? Curr Biol 1997;7:R94-6.
23. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin MA. Cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997; 388:548-54.
24. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio AF, Sonensheim GE. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer. Cancer Res 2001;61:3810-8.
25. Haskell H, Natarajan M, Hecker TP, et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res 2003;9:2157-65.
26. Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor of apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem 2000;275:16309-15.
27. Kasahara T, Koguchi E, Funakoshi M, Yokota E, Sonoda Y. Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Antioxid Redox Signal 2002;4:491-9.
28. Clerck YA, Shimada H, Gonzalez-Gomez I, Rafel C. Tumoral invasion in the central nervous system. J Neurooncol 1994;18:111-21.
29. Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000;156:529-36.
30. Anttila MA, Tammi RH, Tammi MI, Syrjänen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000;60:150-5.
31. Pirinen R, Tammi R, Tammi M, et al. Prognostic value of hyaluronan expression in non-small-cell lung cancer: increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001;95: 12-7.
32. Lipponen P, Aaltomaa S, Tammi R, Tammi M, Agren U, Kosma VM. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer 2001;7:849-56.
33. Posey JT, Soloway MS, Ekici S, et al. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res 2003;63:2638-44.
34. Akiyama Y, Jung S, Salhia B, et al. Hyaluronate receptors mediating glioma cell migration and proliferation. J Neurooncol 2001;53:115-27.
35. Newcomb EW, Lukyanov Y, Schnee T, et al. The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo . Anticancer Drugs 2007;18:875-82.